The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.

The integrated system is now being used in real-world care settings and is widely available for people with type 1 diabetesMANCHESTER, N.H. and GERMANTOWN, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ...

Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from ...

This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health consequences or death. Anna Gragert (she/her/hers) was previously the ...

Feb. 4 (UPI) --Officials for Abbott Diabetes Care have recalled some of the company's FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitor sensors for people with diabetes. The Food ...

Objectives This study aimed to evaluate the effectiveness, safety and costs of FreeStyle Libre (FSL) glucose monitoring system for children and adolescents with type 1 diabetes mellitus (T1DM) in ...

mylife Loop powered by mylife CamAPS FX becomes the first automated insulin delivery system in Canada compatible with two glucose monitoring systems for people living with type 1 diabetes MONTRÉAL, ...

Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus devices have been recalled Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has been working at PEOPLE since 2024, and was previously ...

The U.S. Food and Drug Administration has issued an alert for “a potentially high-risk issue” regarding two glucose monitor sensors that have been malfunctioning and linked to multiple fatalities. The ...

The U.S. Food and Drug Administration is warning people to stop using certain types of glucose monitor sensors after the company that makes them, Abbott Diabetes Care, said the devices were linked to ...

Millions of people rely on continuous glucose monitors to help manage diabetes. But a new alert from the U.S. Food and Drug Administration warns that some sensors from Abbott may give incorrect blood ...

Abbott Diabetes Care said it had received reports of more than 700 injuries that may be associated with malfunctioning sensors. By Amanda Holpuch The Food and Drug Administration said on Tuesday that ...